Howard Franklin
Directeur Technique/Scientifique/R&D chez ASSERTIO HOLDINGS, INC.
Profil
Howard J.
Franklin is currently a Senior Vice President-Medical at Assertio Holdings, Inc. Prior to this, he worked as the Chief Medical Officer at Salix Pharmaceuticals Ltd.
from 2018 to 2022.
He also held the position of Chief Medical Officer at Finch Therapeutics Group, Inc. Dr. Franklin has an MBA from LaSalle University, an undergraduate degree from Lehigh University, and a doctorate from Drexel University College of Medicine.
Postes actifs de Howard Franklin
| Sociétés | Poste | Début |
|---|---|---|
| ASSERTIO HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | 06/03/2023 |
Anciens postes connus de Howard Franklin
| Sociétés | Poste | Fin |
|---|---|---|
| SALIX PHARMACEUTICALS, LTD. | Directeur Technique/Scientifique/R&D | 01/03/2022 |
| FINCH THERAPEUTICS GROUP, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Howard Franklin
| Lehigh University | Undergraduate Degree |
| Drexel University College of Medicine | Doctorate Degree |
| LaSalle University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| ASSERTIO HOLDINGS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
